{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:50:00Z","timestamp":1771012200987,"version":"3.50.1"},"reference-count":98,"publisher":"The Microbiological Society of Korea","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Microbiol."],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12275-015-5041-4","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T01:15:00Z","timestamp":1428369300000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Replicating poxviruses for human cancer therapy"],"prefix":"10.71150","volume":"53","author":[{"given":"Manbok","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4586","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"key":"5041_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11060-011-0606-5","volume":"104","author":"M. Alkassar","year":"2011","unstructured":"Alkassar, M., G\u00e4rtner, B., Roemer, K., Graesser, F., Rommelaere, J., Kaestner, L., Haeckel, I., and Graf, N. 2011. The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo. J. Neurooncol. 104, 715\u2013727.","journal-title":"J. Neurooncol"},{"key":"5041_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2217\/fon.12.7","volume":"8","author":"R.J. Amato","year":"2012","unstructured":"Amato, R.J. and Stepankiw, M. 2012. Evaluation of MVA-5T4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer. Future Oncol. 8, 231\u2013237.","journal-title":"Future Oncol"},{"key":"5041_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1006\/viro.1998.9123","volume":"244","author":"G. Antoine","year":"1998","unstructured":"Antoine, G., Scheiflinger, F., Dorner, F., and Falkner, F.G. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology\n                  244, 365\u2013396.","journal-title":"Virology"},{"key":"5041_CR4","volume-title":"Vet. Comp. Oncol","author":"K. Autio","year":"2014","unstructured":"Autio, K., Knuuttila, A., Kipar, A., Ahonen, M., Parviainen, S., Diaconu, I., Kanerva, A., Hakonen, T., V\u00e4h\u00e4-Koskela, M., and Hemminki, A. 2014. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies. Vet. Comp. Oncol. In press."},{"key":"5041_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/infdis\/136.3.453","volume":"136","author":"D. Baxby","year":"1977","unstructured":"Baxby, D. 1977. The origins of vaccinia virus. J. Infect. Dis. 136, 453\u2013455.","journal-title":"J. Infect. Dis"},{"key":"5041_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/182195a0","volume":"182","author":"W.G. Bearcroft","year":"1958","unstructured":"Bearcroft, W.G. and Jamieson, M.F. 1958. An outbreak of subcutaneous tumours in rhesus monkeys. Nature\n                  182, 195\u2013196.","journal-title":"Nature"},{"key":"5041_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.virol.2005.01.006","volume":"333","author":"T. Brandt","year":"2005","unstructured":"Brandt, T., Heck, M.C., Vijaysri, S., Jentarra, G.M., Cameron, J.M., and Jacobs, B.L. 2005. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response. Virology\n                  333, 263\u2013270.","journal-title":"Virology"},{"key":"5041_CR8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1128\/JVI.75.2.850-856.2001","volume":"75","author":"T.A. Brandt","year":"2001","unstructured":"Brandt, T.A. and Jacobs, B.L. 2001. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J. Virol. 75, 850\u2013856.","journal-title":"J. Virol"},{"key":"5041_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/317813a0","volume":"317","author":"R.M. Buller","year":"1985","unstructured":"Buller, R.M., Smith, G.L., Cremer, K., Notkins, AL., and Moss, B. 1985. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature\n                  317, 813\u2013815.","journal-title":"Nature"},{"key":"5041_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0264-410X(96)00195-8","volume":"15","author":"M.W. Carroll","year":"1997","unstructured":"Carroll, M.W., Overwijk, W.W., Chamberlain, R.S., Rosenberg, S.A., Moss, B., and Restifo, N.P. 1997. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model. Vaccine\n                  15, 387\u2013394.","journal-title":"Vaccine"},{"key":"5041_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1017\/S0950268808000836","volume":"137","author":"B. Carroll","year":"2009","unstructured":"Carroll, B., Russell, P., Gurnell, J., Nettleton, P., and Sainsbury, A.W. 2009. Epidemics of squirrel pox virus disease in red squirrels (Sciurus vulgaris): temporal and serological findings. Epidemiol. Infect. 137, 257\u2013265.","journal-title":"Epidemiol. Infect"},{"key":"5041_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-virology-031413-085442","volume":"1","author":"W.M. Chan","year":"2014","unstructured":"Chan, W.M. and McFadden, G. 2014. Oncolytic Poxviruses. Annu. Rev. Virol. 1, 191\u2013214.","journal-title":"Annu. Rev. Virol"},{"key":"5041_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00002371-200101000-00006","volume":"24","author":"B. Chen","year":"2001","unstructured":"Chen B., Timiryasova, T.M., Haghighat, P., Andres, M.L., Kajioka, E.H., Dutta-Roy, R., Gridley, D.S., and Fodor, I. 2001. Lowdose vaccinia virus-mediated cytokine gene therapy of glioma. J. Immunother. 24, 46\u201357.","journal-title":"J. Immunother"},{"key":"5041_CR14","doi-asserted-by":"publisher","first-page":"e89521","DOI":"10.1371\/journal.pone.0089521","volume":"9","author":"L.M. Collins","year":"2014","unstructured":"Collins, L.M., Warnock, N.D., Tosh, D.G., McInnes, C., Everest, D., Montgomery, W.I., Scantlebury, M., Marks, N., Dick, J.T., and Reid, N. 2014. Squirrelpox virus: assessing prevalence, transmission and environmental degradation. PLoS One\n                  9, e89521.","journal-title":"PLoS One"},{"key":"5041_CR15","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00018-011-0910-4","volume":"69","author":"C.H. Coschi","year":"2012","unstructured":"Coschi, C.H. and Dick, F.A. 2012. Chromosome instability and deregulated proliferation: an unavoidable duo. Cell Mol. Life Sci. 69, 2009\u20132024.","journal-title":"Cell Mol. Life Sci"},{"key":"5041_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bmj.1.5745.363","volume":"1","author":"A.W. Downie","year":"1971","unstructured":"Downie, A.W., Taylor-Robinson, C.H., Caunt, A.E., Nelson, G.S., Manson-Bahr, P.E., and Matthews, T.C. 1971. Tanapox: a new disease caused by a pox virus. Br. Med. J.\n                  1, 363\u2013368.","journal-title":"Br. Med. J."},{"key":"5041_CR17","first-page":"4955","volume":"59","author":"I. Drexler","year":"1999","unstructured":"Drexler, I., Antunes, E., Schmitz, M., W\u00f6lfel, T., Huber, C., Erfle, V., Rieber, P., Theobald, M., and Sutter, G. 1999. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma- specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo. Cancer Res. 59, 4955\u20134963.","journal-title":"Cancer Res"},{"key":"5041_CR18","first-page":"527","volume":"138","author":"J.P. Duff","year":"1996","unstructured":"Duff, J.P., Scott, A., and Keymer, I.F. 1996. Parapox virus infection of the grey squirrel. Vet. Rec. 138, 527.","journal-title":"Vet. Rec"},{"key":"5041_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF02962244","volume":"26","author":"P.D. Ellner","year":"1998","unstructured":"Ellner, P.D. 1998.Smallpox: gone but not forgotten. Infection\n                  26, 263\u2013269.","journal-title":"Infection"},{"key":"5041_CR20","first-page":"1023","volume":"21","author":"C. Espana","year":"1971","unstructured":"Espana, C. 1971. Review of some outbreaks of viral disease in captive nonhuman primates. Lab. Anim. Sci. 21, 1023\u20131031.","journal-title":"Lab. Anim. Sci"},{"key":"5041_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/mt.2010.14","volume":"18","author":"L. Evgin","year":"2010","unstructured":"Evgin, L., V\u00e4h\u00e4-Koskela, M., Rintoul, J., Falls, T., Le Boeuf, F., Barrett, J.W., Bell, J.C., and Stanford, M.M. 2010. Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity. Mol. Ther. 18, 896\u2013902.","journal-title":"Mol. Ther"},{"key":"5041_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1098\/rspb.1983.0039","volume":"218","author":"F. Fenner","year":"1983","unstructured":"Fenner, F. 1983. The Florey lecture, 1983. Biological control, as exemplified by smallpox eradication and myxomatosis. Proc. R Soc. Lond B Biol. Sci. 218, 259\u2013285.","journal-title":"Proc. R Soc. Lond B Biol. Sci"},{"key":"5041_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.20506\/rst.29.1.1964","volume":"29","author":"F. Fenner","year":"2010","unstructured":"Fenner, F. 2010. Deliberate introduction of the European rabbit, Oryctolagus cuniculus, into Australia. Rev. Sci. Tech. 29, 103\u2013111.","journal-title":"Rev. Sci. Tech"},{"key":"5041_CR24","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3390\/v6052122","volume":"6","author":"I. Gentschev","year":"2014","unstructured":"Gentschev, I., Patil, S.S., Petrov, I., Cappello, J., Adelfinger, M., and Szalay, A.A. 2014. Oncolytic virotherapy of canine and feline cancer. Viruses\n                  6, 2122\u20132137.","journal-title":"Viruses"},{"key":"5041_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10549-014-3180-7","volume":"148","author":"S. Gholami","year":"2014","unstructured":"Gholami, S., Marano, A., Chen, N.G., Aguilar, R.J., Frentzen, A, Chen, C.H., Lou, E., Fujisawa, S., Eveno, C., Belin, L., et al. 2014. A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer. Breast Cancer Res. Treat. 148, 489\u2013499.","journal-title":"Breast Cancer Res. Treat"},{"key":"5041_CR26","first-page":"3396","volume":"59","author":"M.F. Gnant","year":"1999","unstructured":"Gnant, M.F., Puhlmann, M., Alexander, H.R. Jr, and Bartlett, D.L. 1999. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice. Cancer Res. 59, 3396\u20133403.","journal-title":"Cancer Res"},{"key":"5041_CR27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0022-5347(05)65755-2","volume":"166","author":"L.G. Gomella","year":"2001","unstructured":"Gomella, L.G., Mastrangelo, M.J., McCue, P.A., Maguire, H.C. Jr, Mulholland, S.G., and Lattime, E.C. 2001. Phase i study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer. J. Urol. 166, 1291\u20131295.","journal-title":"J. Urol"},{"key":"5041_CR28","doi-asserted-by":"crossref","unstructured":"G\u00f3mez, C.E., Perdiguero, B., Garc\u00eda-Arriaza, J., and Esteban, M. 2103. Clinical applications of attenuated MVA poxvirus strain. Expert. Rev. Vaccines\n                  12, 1395\u20131416.","DOI":"10.1586\/14760584.2013.845531"},{"key":"5041_CR29","first-page":"67","volume-title":"European Mammals, Proceedings of the I European Congress of Mammalogy. Museu Bocage","author":"J. Gurnell","year":"1996","unstructured":"Gurnell, J. 1996. The grey squirrel in Britain: problems for management and lessons for Europe, pp. 67\u201381. In Mathias, M.L., Santos-Reis, M., Amori, G., Libois, R., Mitchell-Jones, A., et al. (eds.). European Mammals, Proceedings of the I European Congress of Mammalogy. Museu Bocage."},{"key":"5041_CR30","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","volume":"289","author":"J.S. Halsell","year":"2003","unstructured":"Halsell, J.S., Riddle, J.R., Atwood, J.E., Gardner, P., Shope, R., Poland, G.A., Gray, G.C., Ostroff, S., Eckart, R.E., Hospenthal, D.R., et al. 2003. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA\n                  289, 3283\u20133289.","journal-title":"JAMA"},{"key":"5041_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ygyno.2010.10.031","volume":"120","author":"A.D. Hartkopf","year":"2011","unstructured":"Hartkopf, A.D., Fehm, T., Wallwiener, D., and Lauer, U. 2011. Oncolytic virotherapy of gynecologic malignancies. Gynecol. Oncol. 120, 302\u2013310.","journal-title":"Gynecol. Oncol"},{"key":"5041_CR32","first-page":"4","volume":"50","author":"S. Hashizume","year":"2004","unstructured":"Hashizume, S. 2004. Develoment of the attenuated Smallpox vaccine, LC16m8, produced by cell culture (translated from Japanese). Modern. Media\n                  50, 4\u20139.","journal-title":"Modern. Media"},{"key":"5041_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0966-842X(01)02163-1","volume":"9","author":"R.A. Hayes","year":"2001","unstructured":"Hayes, R.A. and Richardson, B.J. 2001. Biological control of the rabbit in Australia: lessons not learned? Trends Microbiol. 9, 459\u2013460.","journal-title":"Trends Microbiol"},{"key":"5041_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nm.3089","volume":"19","author":"J. Heo","year":"2013","unstructured":"Heo, J., Reid, T., Ruo, L., Breitbach, C.J., Rose, S., Bloomston, M., Cho, M., Lim, H.Y., Chung, H.C., Kim, C.W., et al. 2013. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat. Med. 19, 329\u2013336.","journal-title":"Nat. Med"},{"key":"5041_CR35","first-page":"117","volume-title":"64th Bacteriological Proceedings, American Society for Microbiology","author":"Y.F. Herman","year":"1964","unstructured":"Herman, Y.F. 1964. Isolation and characterization of a naturally occurring poxvirus of raccoons [abstract]. 64th Bacteriological Proceedings, American Society for Microbiology. p. 117."},{"key":"5041_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/gt.2009.132","volume":"17","author":"C.T. Hiley","year":"2010","unstructured":"Hiley, C.T., Yuan, M., Lemoine, N.R., and Wang, Y. 2010. Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours. Gene Ther. 17, 281\u2013287.","journal-title":"Gene Ther"},{"key":"5041_CR37","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/mt.2011.36","volume":"19","author":"M. Hikichi","year":"2011","unstructured":"Hikichi, M., Kidokoro, M., Haraguchi, T., Iba, H., Shida, H., Tahara, H., and Nakamura, T. 2011. MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy. Mol. Ther. 19, 1107\u20131115.","journal-title":"Mol. Ther"},{"key":"5041_CR38","first-page":"283","volume":"975","author":"V. Hochstein-Mintzel","year":"1975","unstructured":"Hochstein-Mintzel, V., Hanichen, T., Huber, H.C., and Stickl, H. 1975. Vaccine- and variola-protective effect of the modified vaccinia strain MVA in intramuscular immunization [in German]. Zentralbl Bakteriol [Orig A]\n                  975, 283\u2013297.","journal-title":"Zentralbl Bakteriol [Orig A]"},{"key":"5041_CR39","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s007050050461","volume":"143","author":"F.M. Housawi","year":"1998","unstructured":"Housawi, F.M., Roberts, G.M., Gilray, J.A., Pow, I., Reid, H.W., Nettleton, P.F., Sumption, K.J., Hibma, M.H., and Mercer, A.A. 1998. The reactivity of monoclonal antibodies against orf virus with other parapoxviruses and the identification of a 39 kDa immunodominant protein. Arch. Virol. 143, 2289\u20132303.","journal-title":"Arch. Virol"},{"key":"5041_CR40","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.1128\/JVI.75.21.10300-10308.2001","volume":"75","author":"Y. Hu","year":"2001","unstructured":"Hu, Y., Lee, J., McCart, J.A., Xu, H., Moss, B., Alexander, H.R., and Bartlett, D.L. 2001. Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy. J. Virol. 75, 10300\u201310308.","journal-title":"J. Virol"},{"key":"5041_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.gt.3302840","volume":"14","author":"C.F. Hung","year":"2007","unstructured":"Hung, C.F., Tsai, Y.C., He, L., Coukos, G., Fodor, I., Qin, L., Levitsky, H., and Wu, T.C. 2007. Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice. Gene Ther. 14, 20\u201329.","journal-title":"Gene Ther"},{"key":"5041_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","volume":"84","author":"B.L. Jacobs","year":"2009","unstructured":"Jacobs, B.L., Langland, J.O., Kibler, K.V., Denzler, K.L., White, S.D., Holechek, S.A., Wong, S., Huynh, T., and Baskin, C.R. 2009. Vaccinia virus vaccines: past, present and future. Antiviral Res.\n                  84, 1\u201313.","journal-title":"Antiviral Res."},{"key":"5041_CR43","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1128\/JVI.77.10.5877-5888.2003","volume":"77","author":"J.B. Johnston","year":"2003","unstructured":"Johnston, J.B., Barrett, J.W., Chang, W., Chung, C.S., Zeng, W., Masters, J., Mann, M., Wang, F., Cao, J., and McFadden, G. 2003. Role of the serine-threonine kinase PAK-1 in myxoma virus replication. J. Virol. 77, 5877\u20135888.","journal-title":"J. Virol"},{"key":"5041_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF01311044","volume":"106","author":"C. Kaplan","year":"1989","unstructured":"Kaplan, C. 1989. Vaccinia virus: a suitable vehicle for recombinant vaccines? Arch. Virol. 106, 127\u2013139.","journal-title":"Arch. Virol"},{"key":"5041_CR45","doi-asserted-by":"publisher","first-page":"52210","DOI":"10.1074\/jbc.M411033200","volume":"279","author":"G.C. Katsafanas","year":"2004","unstructured":"Katsafanas, G.C. and Moss, B. 2004. Vaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation\/proliferation-associated protein (p137) individually or as a heterodimer. J. Biol. Chem. 279, 52210\u201352217.","journal-title":"J. Biol. Chem"},{"key":"5041_CR46","doi-asserted-by":"publisher","first-page":"e1002950","DOI":"10.1371\/journal.ppat.1002950","volume":"8","author":"P.J. Kerr","year":"2012","unstructured":"Kerr, P.J., Ghedin, E., DePasse, J.V., Fitch, A., Cattadori, I.M., Hudson, P.J., Tscharke, D.C., Read, A.F., and Holmes, E.C. 2012. Evolutionary history and attenuation of myxoma virus on two continents. PLoS Pathog. 8, e1002950.","journal-title":"PLoS Pathog"},{"key":"5041_CR47","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","volume":"24","author":"J. Kenner","year":"2006","unstructured":"Kenner, J., Cameron, F., Empig, C., Jobes, D.V., and Gurwith, M. 2006. LC16m8: an attenuated smallpox vaccine. Vaccine\n                  24, 7009\u20137022.","journal-title":"Vaccine"},{"key":"5041_CR48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3181\/00379727-82-20099","volume":"82","author":"L. Kilham","year":"1953","unstructured":"Kilham, L., Herman, C.M., and Fisher, E.R. 1953. Naturally occurring fibromas of grey squirrels related to Shope\u2019s rabbit fibroma. Proc. Soc. Exp. Biol. Med. 82, 298\u2013301.","journal-title":"Proc. Soc. Exp. Biol. Med"},{"key":"5041_CR49","volume-title":"The 40th annual meeting of Korean Cancer Association","author":"M. Kim","year":"2014","unstructured":"Kim, M., Ahn, J.S., Yun, C.O., and Kim, BY. 2014a. Squirrel poxvirus as a novel oncolytic agent. The 40th annual meeting of Korean Cancer Association. Seoul Korea. June 20."},{"key":"5041_CR50","volume-title":"Therapeutic or preventive pharmacological composition of squirrelpox virus for anticancer therapeutics (Translated in Korean)","author":"M. Kim","year":"2014","unstructured":"Kim, M., Ahn, J.S., Yun, C.O., and Kim, B.Y. 2014b. Therapeutic or preventive pharmacological composition of squirrelpox virus for anticancer therapeutics (Translated in Korean). Korean patent No.: 10-1370620 Date of Patent grant: Feb 27, 2014."},{"key":"5041_CR51","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1038\/sj.onc.1210189","volume":"26","author":"M. Kim","year":"2007","unstructured":"Kim, M., Egan, C., Alain, T., Urbanski, S.J., Lee, P.W., Forsyth, P.A., and Johnston, R.N. 2007. Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells. Oncogene\n                  26, 4124\u20134134.","journal-title":"Oncogene"},{"key":"5041_CR52","volume-title":"Tumor suppressor-based susceptibility of hyperproliferative cells to oncolytic viral therapy","author":"M. Kim","year":"2014","unstructured":"Kim, M. and Johnston, R.N. 2014. Tumor suppressor-based susceptibility of hyperproliferative cells to oncolytic viral therapy. Chinese patent No.: 200980126543.5 Date of Patent grant: July 30, 2014."},{"key":"5041_CR53","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1038\/leu.2009.219","volume":"23","author":"M. Kim","year":"2009","unstructured":"Kim, M., Madlambayan, G.J., Rahman, M.M., Smallwood, S.E., Meacham, A.M., Hosaka, K., Scott, E.W., Cogle, C.R., and Mc-Fadden, G. 2009. Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells. Leukemia\n                  23, 2313\u20132317.","journal-title":"Leukemia"},{"key":"5041_CR54","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1038\/onc.2010.137","volume":"29","author":"M. Kim","year":"2010","unstructured":"Kim, M., Williamson, C.T., Prudhomme, J., Bebb, D.G., Riabowol, K., Lee, P.W., Lees-Miller, S.P., Mori, Y., Rahman, M.M., Mc-Fadden, G., et al. 2010. The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status. Oncogene\n                  29, 3990\u20133996.","journal-title":"Oncogene"},{"key":"5041_CR55","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0042-6822(89)90113-X","volume":"172","author":"J.C. Knight","year":"1989","unstructured":"Knight, J.C., Novembre, F.J., Brown, D.R., Goldsmith, C.S., and Esposito, J.J. 1989. Studies on Tanapox virus. Virology\n                  172, 116\u2013124.","journal-title":"Virology"},{"key":"5041_CR56","first-page":"8","volume":"1","author":"G.V. Kochneva","year":"2012","unstructured":"Kochneva, G.V., Sivolobova, G.F., Iudina, K.V., Babkin, I.V., Chumakov, P.M., and Netesov, S.V. 2012. Oncolytic poxviruses. Mol. Gen. Mikrobiol. Virusol. 1, 8\u201315.","journal-title":"Mol. Gen. Mikrobiol. Virusol"},{"key":"5041_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1045-1870(03)00032-3","volume":"14","author":"J.M. Lane","year":"2003","unstructured":"Lane, J.M. and Goldstein, J. 2003. Adverse events occurring after smallpox vaccination. Semin. Pediatr. Infect. Dis.\n                  14, 189\u2013195.","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"5041_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/PPO.0b013e3182325e63","volume":"17","author":"C. Larocca","year":"2011","unstructured":"Larocca, C. and Schlom, J. 2011. Viral vector-based therapeutic cancer vaccines. Cancer J.\n                  17, 359\u2013371.","journal-title":"Cancer J."},{"key":"5041_CR59","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/mt.2010.44","volume":"18","author":"F. Le Boeuf","year":"2010","unstructured":"Le Boeuf, F., Diallo, J.S., McCart, J.A., Thorne, S., Falls, T., Stanford, M., Kanji, F., Auer, R., Brown, C.W., Lichty, B.D., et al. 2010. Synergistic interaction between oncolytic viruses augments tumor killing. Mol. Ther. 18, 888\u2013895.","journal-title":"Mol. Ther"},{"key":"5041_CR60","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ygyno.2014.01.009","volume":"132","author":"Y.P. Liu","year":"2014","unstructured":"Liu, Y.P., Wang, J., Avanzato, V.A., Bakkum-Gamez, J.N., Russell, S.J., Bell, J.C., and Peng, K.W. 2014. Oncolytic vaccinia virotherapy for endometrial cancer. Gynecol. Oncol. 132, 722\u2013729.","journal-title":"Gynecol. Oncol"},{"key":"5041_CR61","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.1158\/0008-5472.CAN-05-1201","volume":"65","author":"X. Lun","year":"2005","unstructured":"Lun, X., Yang, W., Alain, T., Shi, Z.Q., Muzik, H., Barrett, J.W., McFadden, G., Bell, J., Hamilton, M.G., Senger, D.L., et al. 2005. Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas. Cancer Res. 65, 9982\u20139990.","journal-title":"Cancer Res"},{"key":"5041_CR62","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/JVI.72.3.2429-2438.1998","volume":"72","author":"E. Mathew","year":"1998","unstructured":"Mathew, E., Sanderson, C.M., Hollinshead, M., and Smith, G.L. 1998. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J. Virol. 72, 2429\u20132438.","journal-title":"J. Virol"},{"key":"5041_CR63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/sj.cgt.7700066","volume":"6","author":"M.J. Mastrangelo","year":"1999","unstructured":"Mastrangelo, M.J., Maguire, H.C. Jr, Eisenlohr, L.C., Laughlin, C.E., Monken, C.E., McCue, P.A., Kovatich, A.J., and Lattime, E.C. 1999. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. Cancer Gene Ther. 6, 409\u2013422.","journal-title":"Cancer Gene Ther"},{"key":"5041_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0147-9571(03)00025-0","volume":"26","author":"A. Mayr","year":"2003","unstructured":"Mayr, A. 2003. Smallpox vaccination and bioterrorism with pox viruses. Comp. Immunol. Microbiol. Infect Dis. 26, 423\u2013430.","journal-title":"Comp. Immunol. Microbiol. Infect Dis"},{"key":"5041_CR65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF01641272","volume":"3","author":"A. Mayr","year":"1975","unstructured":"Mayr, A., Hochstein-Mintzel, V., and Stickl, H. 1975. Passage history, properties, and applicability of the attenuated vaccinia virus strain MVA [in German]. Infectio. 3, 6\u201314.","journal-title":"Infectio"},{"key":"5041_CR66","first-page":"375","volume":"167","author":"A. Mayr","year":"1978","unstructured":"Mayr, A., Stickl, H., Muller, H.K., Danner, K., and Singer, H. 1978. The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism [in German]. Zentralbl Bakteriol [B]\n                  167, 375\u2013390.","journal-title":"Zentralbl Bakteriol [B]"},{"key":"5041_CR67","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/sj.gt.3301237","volume":"7","author":"J.A. McCart","year":"2000","unstructured":"McCart, J.A., Puhlmann, M., Lee, J., Hu, Y., Libutti, S.K., Alexander, H.R., and Bartlett, D.L. 2000. Complex interactions between the replicating oncolytic effect and the enzyme\/prodrug effect of vaccinia-mediated tumor regression. Gene Ther. 7, 1217\u20131223.","journal-title":"Gene Ther"},{"key":"5041_CR68","first-page":"8751","volume":"61","author":"J.A. McCart","year":"2001","unstructured":"McCart, J.A., Ward, J.M., Lee, J., Hu, Y., Alexander, H.R., Libutti, S.K., Moss, B., and Bartlett, D.L. 2001. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res.\n                  61, 8751\u20138757.","journal-title":"Cancer Res."},{"key":"5041_CR69","doi-asserted-by":"publisher","first-page":"12471","DOI":"10.1128\/JVI.78.22.12471-12479.2004","volume":"78","author":"L.H. McCurdy","year":"2004","unstructured":"McCurdy, L.H., Rutigliano, J.A., Johnson, T.R., Chen, M., and Graham, B.S. 2004. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4. J. Virol. 78, 12471\u201312479.","journal-title":"J. Virol"},{"key":"5041_CR70","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrmicro1099","volume":"3","author":"G. McFadden","year":"2005","unstructured":"McFadden, G. 2005. Poxvirus tropism. Nat. Rev. Microbiol. 3, 201\u2013213.","journal-title":"Nat. Rev. Microbiol"},{"key":"5041_CR71","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1099\/vir.0.81966-0","volume":"87","author":"C.J. McInnes","year":"2006","unstructured":"McInnes, C.J., Wood, A.R., Thomas, K., Sainsbury, A.W., Gurnell, J., Dein, F.J., and Nettleton, P.F. 2006. Genomic characterization of a novel poxvirus contributing to the decline of the red squirrel (Sciurus vulgaris) in the UK. J. Gen. Virol. 87, 2115\u20132125.","journal-title":"J. Gen. Virol"},{"key":"5041_CR72","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ijrobp.2013.11.054","volume":"88","author":"L.K. Mell","year":"2014","unstructured":"Mell, L.K., Brumund, K.T., Advani, S.J., Onyeama, S., Daniels, G.A., Weisman, R.A., Martin, P., and Szalay, A.A. 2014. Phase 1 trial of attenuated vaccinia virus (GL-ONC1) delivered intravenously with concurrent cisplatin and radiation therapy in patients with locoregionally advanced head-and-neck carcinoma. Inl. J. Radiation Oncology \u00b7 Biology \u00b7 Physics. 88, 477\u2013478.","journal-title":"Inl. J. Radiation Oncology \u00b7 Biology \u00b7 Physics"},{"key":"5041_CR73","doi-asserted-by":"publisher","first-page":"11873","DOI":"10.1128\/JVI.79.18.11873-11891.2005","volume":"79","author":"S. Morikawa","year":"2005","unstructured":"Morikawa, S., Sakiyama, T., Hasegawa, H., Saijo, M., Maeda, A., Kurane, I., Maeno, G., Kimura, J., Hirama, C., Yoshida, T., et al. 2005. An attenuated LC16m8 smallpox vaccine: analysis of fullgenome sequence and induction of immune protection. J. Virol. 79, 11873\u201311891.","journal-title":"J. Virol"},{"key":"5041_CR74","unstructured":"Moss B. 2013. Poxviridae, pp. 3292\u20133809. In Fields, B.N., Knipe, D.M., and Howley, P.M. (eds.), Fields Virology, Lippincott-Raven, Philadelphia, USA."},{"key":"5041_CR75","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DDDT.S3687","volume":"4","author":"A. Nalca","year":"2010","unstructured":"Nalca, A. and Zumbrun, E.E. 2010. ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug Des. Devel. Ther. 4, 71\u201379.","journal-title":"Drug Des. Devel. Ther"},{"key":"5041_CR76","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/jvi.66.8.4720-4731.1992","volume":"66","author":"A. Opgenorth","year":"1992","unstructured":"Opgenorth, A., Graham, K., Nation, N., Strayer, D., and McFadden, G. 1992. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66, 4720\u20134731.","journal-title":"J. Virol"},{"key":"5041_CR77","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1470-2045(08)70107-4","volume":"9","author":"B.H. Park","year":"2008","unstructured":"Park, B.H., Hwang, T., Liu, T.C., Sze, D.Y., Kim, J.S., Kwon, H.C., Oh, S.Y., Han, S.Y., Yoon, J.H., Hong, S.H., et al. 2008. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial. Lancet Oncol. 9, 533\u2013542.","journal-title":"Lancet Oncol"},{"key":"5041_CR78","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nrc1750","volume":"5","author":"K.A. Parato","year":"2005","unstructured":"Parato, K.A., Senger, D., Forsyth, P.A., and Bell, J.C. 2005. Recent progress in the battle between oncolytic viruses and tumours. Nat. Rev. Cancer\n                  5, 965\u2013976.","journal-title":"Nat. Rev. Cancer"},{"key":"5041_CR79","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/ijc.29068","volume":"136","author":"S. Parviainen","year":"2015","unstructured":"Parviainen, S., Ahonen, M., Diaconu, I., Kipar, A., Siurala, M., V\u00e4h\u00e4-Koskela, M., Kanerva, A., Cerullo, V., and Hemminki, A. 2015. GMCSF-armed vaccinia virus induces an antitumor immune response. Int. J. Cancer\n                  136, 1065\u20131072.","journal-title":"Int. J. Cancer"},{"key":"5041_CR80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.cgt.7700075","volume":"7","author":"M. Puhlmann","year":"2000","unstructured":"Puhlmann, M., Brown, C.K., Gnant, M., Huang, J., Libutti, S.K., Alexander, H.R., and Bartlett, D.L. 2000. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant. Cancer Gene Ther. 7, 66\u201373.","journal-title":"Cancer Gene Ther"},{"key":"5041_CR81","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/oxfordjournals.aje.a121349","volume":"94","author":"D.C. Regnery","year":"1971","unstructured":"Regnery, D.C. 1971. The epidemic potential of Brazilian myxoma virus (Lausanne strain) for three species of North American cottontails. Am. J. Epidemiol. 94, 514\u2013519.","journal-title":"Am. J. Epidemiol"},{"key":"5041_CR82","first-page":"314","volume":"8","author":"M.S. Roberts","year":"2006","unstructured":"Roberts, M.S., Lorence, R.M., Groene, W.S., and Bamat, M.K. 2006. Naturally oncolytic viruses. Curr. Opin. Mol. Ther. 8, 314\u2013321.","journal-title":"Curr. Opin. Mol. Ther"},{"key":"5041_CR83","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3201\/eid0706.010602","volume":"7","author":"S.R. Rosenthal","year":"2001","unstructured":"Rosenthal, S.R., Merchlinsky, M., Kleppinger, C., and Goldenthal, K.L. 2001. Developing new smallpox vaccines. Emerg. Infect. Dis. 7, 920\u2013926.","journal-title":"Emerg. Infect. Dis"},{"key":"5041_CR84","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","volume":"10","author":"S.J. Russell","year":"2012","unstructured":"Russell, S.J., Peng, K.W., and Bell, J.C. 2012. Oncolytic virotherapy. Nat. Biotechnol. 10, 658\u2013670.","journal-title":"Nat. Biotechnol"},{"key":"5041_CR85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1469-1795.2000.tb00107.x","volume":"3","author":"A.W. Sainsbury","year":"2000","unstructured":"Sainsbury, A.W., Nettleton, P., Gilray, J., and Gurnell, J. 2000. Grey squirrels have high seroprevalence to a parapoxvirus associated with deaths in red squirrels. Anim. Conserv. 3, 229\u2013233.","journal-title":"Anim. Conserv"},{"key":"5041_CR86","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1055\/s-0028-1108143","volume":"99","author":"H. Stickl","year":"1974","unstructured":"Stickl, H., Hochstein-Mintzel, V., Mayr, A., Huber, H.C., Schafer, H., and Holzner, A. 1974. MVA vaccination against smallpox: clinical trials with an attenuated live vaccinia virus strain (MVA) [in German]. Dtsch. Med. Wochenschr\n                  99, 2386\u20132392.","journal-title":"Dtsch. Med. Wochenschr"},{"key":"5041_CR87","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/emboj\/17.12.3351","volume":"17","author":"J.E. Strong","year":"1998","unstructured":"Strong, J.E., Coffey, M.C., Tang, D., Sabinin, P., and Lee, P.W. 1998. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J.\n                  17, 3351\u20133362.","journal-title":"EMBO J."},{"key":"5041_CR88","doi-asserted-by":"publisher","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","volume":"89","author":"G. Sutter","year":"1992","unstructured":"Sutter, G. and Moss, B. 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA\n                  89, 10847\u201310851.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5041_CR89","first-page":"103","volume":"8","author":"J. Sypula","year":"2004","unstructured":"Sypula, J., Wang, F., Ma, Y., Bell, J., and McFadden, G. 2004. Myxoma virus tropism in human tumor cells. Gene Ther. Mol. Biol. 8, 103\u2013114.","journal-title":"Gene Ther. Mol. Biol"},{"key":"5041_CR90","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF01317540","volume":"49","author":"E.K. Thomas","year":"1975","unstructured":"Thomas, E.K., Palmer, E.L., Obijeski, J.F., and Nakano, J.H. 1975. Further characterization of Raccoonpox virus. Arch. Virol. 49, 217\u2013227.","journal-title":"Arch. Virol"},{"key":"5041_CR91","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1172\/JCI32727","volume":"117","author":"S.H. Thorne","year":"2007","unstructured":"Thorne, S.H., Hwang, T.H., O\u2019Gorman, W.E., Bartlett, D.L., Sei, S., Kanji, F., Brown, C., Werier, J., Cho, J.H., Lee, D.E., et al. 2007. Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963. J. Clin. Invest. 117, 3350\u20133358.","journal-title":"J. Clin. Invest"},{"key":"5041_CR92","first-page":"133","volume":"11","author":"T.M. Timiryasova","year":"1999","unstructured":"Timiryasova, T.M., Li, J., Chen, B., Chong, D., Langridge, W.H., Gridley, D.S., and Fodor, I. 1999. Antitumor effect of vaccinia virus in glioma model. Oncol. Res. 11, 133\u2013144.","journal-title":"Oncol. Res"},{"key":"5041_CR93","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1098\/rspb.2001.1897","volume":"269","author":"D.M. Tompkins","year":"2002","unstructured":"Tompkins, D.M., Sainsbury, A.W., Nettleton, P., Buxton, D., and Gurnell, J. 2002. Parapoxvirus causes a deleterious disease in red squirrels associated with UK population declines. Proc. R Soc. Lond B Biol. Sci. 269, 529\u2013533.","journal-title":"Proc. R Soc. Lond B Biol. Sci"},{"key":"5041_CR94","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1073\/pnas.0509341103","volume":"103","author":"G. Wang","year":"2006","unstructured":"Wang, G., Barrett, J.W., Stanford, M., Werden, S.J., Johnston, J.B., Gao, X., Sun, M., Cheng, J.Q., and McFadden, G. 2006. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. Proc. Natl. Acad. Sci. USA\n                  103, 4640\u20134645.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5041_CR95","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1017\/S0025727300040825","volume":"26","author":"L. Wilkinson","year":"1982","unstructured":"Wilkinson, L. 1982. Jenner\u2019s smallpox vaccine. The riddle of vaccinia virus and its origin. Med. Hist. 26, 94\u201395.","journal-title":"Med. Hist"},{"key":"5041_CR96","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/mt.2014.194","volume":"23","author":"H.J. Zeh","year":"2015","unstructured":"Zeh, H.J., Downs-Canner, S., McCart, J.A., Guo, Z.S., Rao, U.N., Ramalingam, L., Thorne, S.H., Jones, H.L., Kalinski, P., Wieckowski, E., et al. 2015. First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity. Mol. Ther. 23, 202\u2013214.","journal-title":"Mol. Ther"},{"key":"5041_CR97","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1158\/0008-5472.CAN-14-0876","volume":"74","author":"F.J. Zemp","year":"2014","unstructured":"Zemp, F.J., McKenzie, B.A., Lun, X., Reilly, K.M., McFadden, G., Yong, V.W., and Forsyth, P.A. 2014. Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus. Cancer Res.\n                  74, 7260\u20137273.","journal-title":"Cancer Res."},{"key":"5041_CR98","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.1158\/0008-5472.CAN-07-0146","volume":"67","author":"Q. Zhang","year":"2007","unstructured":"Zhang, Q., Yu, Y.A., Wang, E., Chen, N., Danner, R.L., Munson, P.J., Marincola, F.M., and Szalay, A.A. 2007. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res.\n                  67, 10038\u201310046.","journal-title":"Cancer Res."}],"container-title":["Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-015-5041-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12275-015-5041-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-015-5041-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-015-5041-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:52:56Z","timestamp":1735062776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12275-015-5041-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["5041"],"URL":"https:\/\/doi.org\/10.1007\/s12275-015-5041-4","relation":{},"ISSN":["1225-8873","1976-3794"],"issn-type":[{"value":"1225-8873","type":"print"},{"value":"1976-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"21 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}